FDA Orange Book · active-ingredient family
Indium in-111 chloride
Indium in-111 chloride is approved in 2 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:INDIUM IN 111 CHLORIDE · NDA 019841
2
Brand (NDA)
0
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · injectable
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| INDIUM IN 111 CHLORIDERLD | CURIUM | NDA 019841 | — | Sep 27, 1994 | |
| INDICLORRLD | GE HEALTHCARE | NDA 019862 | — | Dec 29, 1992 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Indium in-111 chloride — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

